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ABSTRACT
The CRT10 gene was identified through screening
of the Saccharomyces cerevisiae deletion library
for hydroxyurea (HU) resistance. CRT10 encodes a
putative957aminoacid,110kDaproteinwithaleucine
repeat and a WD40 repeat near the N-terminus.
Deletion of CRT10 resulted in an enhanced resis-
tance to HU reminiscent of the inactivation of two
other ribonucleotide reductase (Rnr) suppressors,
CRT1 and SML1, which regulate Rnr activity at tran-
scriptional and translational levels, respectively.
Epistatic analysis indicates that CRT10 belongs to
the CRT1 pathway but not the SML1 pathway.
Indeed, deletion of CRT10 enhanced the survival of
the mec1 null mutant and increased basal level and
DNAdamage-inducedexpressionofRNR2andRNR3,
suggesting that Crt10 regulates RNR genes at the
transcriptional level. Furthermore, the dun1 mutation
isepistatictocrt10withrespecttobothHUsensitivity
and RNR gene expression. Interestingly, the expres-
sion of CRT10 itself is induced by DNA damaging
agents and this induction requires DUN1, suggesting
that CRT10 plays a role in cellular response to DNA
damage and replication blocks. The CRT10 function
appears to be achieved by positive regulation of
the CRT1 transcript level, indicating that CRT10 is a
component of the regulatory circuit.
INTRODUCTION
Ribonucleotide reductase (Rnr) catalyzes the rate-limiting
steps in dNTP synthesis. Three classes of Rnr have been iden-
tiﬁed (1). Class I enzymes, which are found in all eukaryotes
and some prokaryotes, consist of an a2b2 tetramer with two
large (a) and two small (b) subunits. The a subunit possesses
binding sites for substrate and allosteric effectors, and the b
subunit contains a binuclear iron complex that interacts with a
speciﬁc tyrosine residue to form a tyrosyl free radical and is
essential for the Rnr activity (2,3). In the budding yeast
Saccharomyces cerevisiae, the large Rnr subunit is encoded
by two highly homologous genes, RNR1 and RNR3 (4). RNR1
is an essential gene, whereas RNR3 is nonessential. RNR1
transcription is tightly regulated during the cell cycle and
moderately induced by DNA damage, whereas RNR3 is
barely transcribed under normal conditions but is highly indu-
cible by DNA damage, increasing up to 100-fold (4). The
small Rnr subunit is encoded by RNR2 and RNR4, both of
which are essential and DNA damage inducible (5–7),
although RNR4 null mutants in some yeast strains appear to
be viable (8).
The tight regulation of Rnr during the cell cycle and by
DNA damage is thought to be crucial for the maintenance
of balanced dNTP pools for high-ﬁdelity DNA replication
and repair (9,10). Failure to provide a sufﬁcient and balanced
dNTP pool may cause misincorporation of dNTPs into DNA,
which in turn results in genetic abnormalities and cell death
(11). The regulation of Rnr involves multiple mechanisms in
budding yeast, including transcriptional regulation (12), pro-
tein (13) and allosteric (11,14) inhibition and subcellular
localization (15). The DNA damage-induced transcriptional
activation is mediated by the cell cycle checkpoint genes. The
stalling of the replication fork or DNA damage triggers a DNA
damage checkpoint pathway composed of the protein kinase
cascade Mec1, Rad53 and Dun1 (16). Activated Dun1 phos-
phorylates a Crt1 repressor, and hyper-phosphorylated Crt1 no
longer binds the X-box sequence found in the promoters of
RNR genes, resulting in transcriptional derepression (17).
A second mechanism is Sml1-dependent; Sml1 inhibits the
yeast Rnr activity by binding its large subunit (18–20). Activ-
ated Sml1 levels decrease at S phase and after DNA damage,
resulting in derepression of Rnr activity (13). The inactivation
of Sml1 is caused by post-transcriptional regulation and also
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(13,21), which again testiﬁes to the need for tight Rnr
regulation. The tight regulation of Rnr activity appears to
be true for other organisms, such as ﬁssion yeast (22),
indicating that such regulations are evolutionarily conserved.
It is anticipated that additional genes and/or mechanisms
may be involved in the regulation of Rnr activities. To
investigate this possibility, we utilized the powerful budding
yeast genetic system to identify such genes, and report here
the identiﬁcation of a novel gene, CRT10, whose mutation
enhances hydroxyurea (HU) resistance. Genetic characteriza-
tion indicates that CRT10 is involved in the transcriptional
regulation of RNR genes.
MATERIALS AND METHODS
S.cerevisiae strains, cell culture and transformation
The yeast strains used in this study are listed in Table 1. Yeast
cells were cultured at 30 C either in a YPD rich medium or in
a synthetic dextrose (SD) medium supplemented with amino
acids and bases (23). Yeast cell transformation was performed
by using a dimethyl sulfoxide (DMSO)-enhanced method as
described (24). For targeted gene integration, plasmid DNA
was digested with restriction enzymes and the DNA was
precipitated prior to transformation.
Screening of yeast deletion library
The yeast haploid deletion library was created by the
Saccharomyces Genome Deletion Project consortium and
purchased from Research Genetics (Invitrogen, Carlsbad,
CA). The deletion mutants were replicated on to YPD and
YPD + 80 mM HU. Plates were incubated at 30 C for 3 days
before evaluation.
Cell killing by DNA-damaging agents
HU and methyl methanesulfonate (MMS) were purchased
from Sigma–Aldrich (St. Louis, MO). Log phase yeast cells
were diluted to 1 · 10
7 cells/ml, and 10-fold serial dilutions
were made. Aliquots of 10 ml of diluted cells were spotted on
the appropriate plates, and incubated at 30 C for 3 days.
Plasmids and plasmid construction
Plasmid manipulation was performed using enzymes
purchased from Invitrogen and New England Biolabs
(Beverly, MA) as recommended by the manufacturers.
Plasmids pZZ2 and pZZ18, containing the RNR3-lacZ and
RNR2-lacZ reporter genes, respectively (25), were kindly
provided by Dr S. Elledge (Harvard Medical School, Boston,
MA). To construct crt10D::LEU2 disruption cassettes, the
2.8 kb CRT10 open reading frame was PCR-ampliﬁed from
genomic DNA with primer CRT10-1: 50-CCGGAATT-
CATGCCCCCTCAGATTCCCAATG-30, and CRT10-2: 50-
CGGGTCGACCTATTGTTGAGTTGTTCCATG. The PCR
product was cloned into pBluescript SK (Stratagene, La
Jolla, CA) to form pBS-CRT10. The resulting plasmid
pBS-CRT10 was digested by HpaI and MscI to remove the
fragment encoding 60–871 amino acid, and then ligated with
a BglII linker to create plasmid pBS-crt10D.ALEU2 marker
was inserted into the plasmid to form pcrt10D::LEU2. For
CRT10 disruption, pcrt10D::LEU2 was digested by AvaI
and NcoI prior to yeast transformation.
Yeast tetrad analysis
For tetrad analysis, parental haploid strains U953-61A and
WX1158 were mated on SD-Trp-His-Leu plates and trans-
ferred into sporulation medium. After 3 days incubation at
room temperature, the spores were dissected and incubated
for 3 days prior to phenotyping by replica plating to YPD and
SD medium containing appropriate combinations of amino
acids.Tominimize thepossibilityofdissectionoffalsetetrads,
digestion of asci was carried out by incubating with NEE-154
glusulase (Dupont Company, Wilmington, DE, USA) at room
temperature for 10 min immediately before dissecting. The
tetrads were dissected with a Singer MSM micromanipulator
(Singer Instrument Co., Somerset, England).
RNA extraction, northern hybridization and
real-time PCR
Yeast cells with or without treatment were harvested from
early log phase culture (2 · 10
7 cells/ml). Total RNA was
prepared using an RNeasy midi Kit (Qiagen, Valencia, CA).
Northern blot analysis was performed as described previously
(26). The DNA probe was labeled with [a-
32P]dCTP using a
Random Primer Labeling kit from Invitrogen. The CRT10
PCR product containing the entire open reading frame and
the 1.6 kb ACT1 fragment from pAA93 (a gift from
Dr F. Sherman, Rochester University, NY) were used as
probes.
For real-time PCR, the extracted RNA was treated with a
DNA-free  Kit from Ambion (Austin, TX) to remove
contaminating DNA. The treated RNA was used as template
to perform reverse transcription through the Thermoscript 
RT–PCR system (Invitrogen). Real-time PCR was carried out
and analyzed by the MiniOpticon  real-time PCR system
(BioRad, Hercules, CA). Primers used in the real-time PCR
were: ACT1-1 (50-TGGCCGGTAGAGATTTGACTGACT-
30); ACT1-2 (50-AGAAGCCAAGATAGAACCACCAAT-30);
TUP1-1 (50-CCACCACGTCGACGGATAACAATA-30);
Table 1. Saccharomyces cerevisiae strains
Strain Genotype Source
BY4741 MATa his3 leu2 met15 ura3 Invitrogen
WXY1152 BY4741 with crt10D::KanMX Invitrogen
WXY1153 BY4741 with crt1D::KanMX Invitrogen
WXY1154 BY4741 with crt1D::KanMX
crt10D::LEU2
This study
WXY1155 BY4741 with dun1D::KanMX Invitrogen
WXY1156 BY4741 with dun1D::KanMX
crt10D::LEU2
This study
HK578-10A
a MATa ade2-1 can1-100 his3-11,15
leu2-3112 trp-1-1 ura3-1
H. Klein
WXY1157
a HK578-10A with crt10D::LEU2 This study
HK578-10D
a MATa ade2-1 can1-100 his3-11,15
leu2-3112 trp-1-1 ura3-1
H. Klein
WXY1158
a HK578-10D with crt10D::LEU2 This study
U952-3B
a MATa sml1D::HIS3 R. Rothstein
U953-61A
a MATa mec1D::TRP1 sml1D::HIS3 R. Rothstein
WXY1159
a U952-3B with crt10D::LEU2 This study
aThese strains are isogenic to W303 but contain a wild-type RAD5 gene.
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SSN6-1 (50-GCCCAAGCTCCCCAACC-30); SSN6-2 (50-
CTGTGCGCCAATTACTGAAGG-30);CRT1-1(50-GGTCG-
CCCGTTAAACAGAGTA-30) and CRT1-2 (CGTGGGCGA-
TATAGAGTTAGAGT-30); MAG1-R1 (50-GCGGTGCATT-
TCCTGATTA-30) and MAG1-R2 (50-TCGCGAGCCTC-
CAAAGTAT-30); and RNR3-R1 (50-GCCTCCGCTGCTA-
TTCAA-30) and RNR3-R2 (50-CAGATGCCGCCTTTT-
GTT-3). The relative transcript level of each treatment was
determined by a method and formula as described (27).
b-Galactosidase (b-gal) assay
The b-gal assay was performed as described previously
(26,28). Brieﬂy, 0.5 ml of overnight yeast culture was used
to inoculate 2.5 ml of fresh SD selective medium and incuba-
tion was continued for another 2 h. At this point, chemicals
were added at the concentration indicated and cells were
incubated for another 4 h. One ml of cell suspension was
used for determining cell titer at OD600nm, and the remaining
cells were used for the b-gal assay. The b-gal activity is
expressed in Miller units (29).
RESULTS
Identification of CRT10
HU is a potent inhibitor of Rnr, leading to depleted dNTP
pools, the subsequent stalling of the replication forks and S
phase cell cycle arrest (2,30). In order to identify S.cerevisiae
genes whose mutation alters cellular sensitivity to HU, we
performed an HU resistance screen with the haploid yeast
mutant library consisting of 4850 individual gene deletion
strains. Among HU-resistant mutants, the YOL063c deletion
mutant displayed signiﬁcant resistance to HU and this gene
has not been previously characterized. YOL063c encodes a
putative 957 amino acid, 109 kDa protein and was designated
as CRT10, after the nine previously described putative CRT
(constitutive RNR transcription) regulator genes (25).
The predicted Crt10 contains leucine repeats at residues
105–145 with a sequence L-X9-L-X8-L-X6-L-X6-L-X6-L, a
putative transmembrane domain at residues 191–206, and
one copy of the Trp-Asp (WD) repeat motif at residues
253–267 (31) (Figure 1). WD-repeat proteins are found in
all eukaryotes and implicated in a wide range of crucial
functions. These proteins typically contain 4–16 copies of
the WD motif (32); however, only one WD repeat motif
was found in Crt10.
A database search with the Crt10 protein sequence revealed
several homologous sequences in other organisms. The closest
homologs are found in members within the Saccharomyces
family. In addition, a putative protein (ADR329Wp) in
Eremothecium gossypii and Candida albicans hypothetical
protein (CAG58307.1) show signiﬁcant homology to Crt10;
a hypothetic protein (SPBC27B12.05) from Schizosaccharo-
myces pombe also shows limited homology to Crt10 (data not
shown). No polypeptide sequence in the worm, mouse or
human genome database has signiﬁcant similarity to Crt10,
suggesting that Crt10 may be unique to lower eukaryotes,
possibly within unicellular eukaryotic microorganisms.
Deletion of CRT10 enhances survival of the mec1D
mutant
The crt10 mutant was originally isolated for its enhanced
resistance to HU killing in a library screen. We compared
the crt10D mutant to its isogenic wild-type strain BY4741
and found that it indeed displayed an enhanced resistance
to HU (Figure 2A). In order to rule out the possibility
that this crt10 strain contains additional unknown mutation(s),
we made a crt10D::LEU2 deletion cassette and created a
crt10 null mutant in a different strain background. As
shown in Figure 2B, targeted deletion of CRT10 also resulted
in a similar HU-resistant phenotype. Deletion of CRT10 led
to slightly enhanced resistance to MMS, but not to ultra-
violet (UV) (data not shown), suggesting that Crt10 probably
functions speciﬁcally in a pathway in response to either
DNA replication arrest or an imbalance of the endogenous
nucleotide pool.
To distinguish the above two possibilities, we took advant-
age of a cell cycle checkpoint mutant, mec1. It is known that
the mec1 null mutant is inviable; however, its inviability is due
to the decreased expression of RNR genes rather than the loss
of checkpoint functions. Hence, its viability can be rescued by
deletion of either the Rnr inhibitor gene SML1 (18) or the RNR
repressor CRT1 (17), or by overexpression of RNR1 (33). We
reasoned that if Crt10 acts upon Rnr expression/activity, dele-
tion of CRT10 may be able to rescue the mec1D inviability,
MPPQIPNENDDLFTRWLKSRAIIQRAVSTRECFDSEVFLASGGWNITNEIITLKKYYQLK  60 
WPNSSCNSFHPKTVEFIKERLHNLEEHDSSWKIPNPAYSFKKAFLEDTKSAFSNLEPVWG 120 
PSRLLNPAELLLPQDEKLLVQEIPLEFAPFQYTNRFAYGGLQFKNNLFVTYGSYSFLAAG 180 
QCVEVHNFDILLNVSSLEICHALLPVIIPDDGDVRNFRNSSYVKFKDTQFNSIPELCSIN 240 
FMKICNFMHQDFLLACGDNGIVYIWEINKVIKIFNKFTSDILGGKDNSRERYINVDPYMV 300 
LRVEESCWSVDVIDINGIIYIAVGHNKPGVTVFAFDKDVKKERRYIRPLDLPSSHNVPCV 360 
NFVPNSKDSVGYITLSYCSIFGNVVTVKLKEHDCTILTSFLDTQFFGDDLWTITPLTKKD 420 
FAKVDNFELLNLNYQDGFKESMLYSICRDDFLLGYYCDNAYLSGNFGIGTLLNQFQVPVT 480 
DLRLTSSAGIPDEVIPLRFTSFDRNYTTTGSIKYEYSREDFALILHAGDLDDMNDAVTKN 540 
TSCEQHLHQWTFWEDSGYKHYRATERGFSKYKDIINTFPQLITPSGRNKTSQYQNTSGRK 600 
ICEPSTYKLTDLENDIEDISREFNRSIRNLKMDKQRQLRTSKEFKSLSSVNHIPNIESGN 660 
FLWYNTDAAADWRTLFGKDLNTVLKDPEICSLQLNSTEEDDVNSDPENEESGSSLTSFQR 720 
RYRDTEQRAHLKSESQKSWGFHNYVRNVKRLLESAVPGSEDSPLGYQLSEMHDEFFFLTT 780 
AHRLVLMKANPLIIISATHHEIFPLDGVVTCASKSLLQALNRINFVCHIKELNCIAVASQ 840 
LGLISLLRLTEYRGIYSFRQEYILGWEVQDPVNPSPECRCNRNLFDAPMYGADGESSDTY 900 
CGVCDVYFPMGDICGLDYTYASDSEELKRKGYATLYVASRGSLRAFKITTEHGTTQQ    957 
Figure 1. The deduced S.cerevisiae Crt10/YOL063c amino acid sequence. The putative leucine repeat (underlined), transmembrane domain (boldface) and WD
repeat (boldface and italicized) are indicated.
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should not be able to rescue mec1D. The mec1D sml1D double
mutant was crossed to crt10D in an isogenic background.
Haploid spores recovered from 40 tetrads were genotyped
by replica plating to appropriate media. No viable crt10
mec1 double mutant colonies were obtained. However,
under the microscope, it was found that the mec1D mutant
cells did not extend beyond two cell divisions, whereas the
crt10D mec1D double mutant cells formed microcolonies
containing up to several hundred cells (Figure 2C). This is
in contrast to the sml1 mec1 double mutant from the same
experiment, which formed visible colonies (data not shown).
Hence, deletion of CRT10 appears to rescue mec1D cells from
immediate death.
CRT10 belongs to the CRT1 regulatory pathway
Since deletion of CRT10 results in HU resistance and partially
rescues the mec1D mutant, it is most likely involved in the
regulation of Rnr activity. CRT1 and SML1 are two genes
regulating Rnr by different mechanisms, the former at the
transcriptional level (17) and the latter at the protein activity
level (18). Indeed, we isolated both crt1 and sml1 during the
initial mutant library screen. In order to ask if CRT10 belongs
to one of the two regulatory pathways, epistasis analysis was
performed by creating crt10D crt1D and crt10D sml1D double
mutants and comparing them to the corresponding single
mutants with respect to HU resistance. The crt10D crt1D
double mutant showed the same level of resistance to HU
as the crt1D single mutant (Figure 2A), indicating that
CRT10 belongs to the same pathway as CRT1. In contrast,
the phenotypic effect of crt10D appears to be additive with
sml1D (Figure 2B), suggesting that CRT10 does not belong to
the same regulatory pathway as SML1.
ThetranscriptlevelofRNRiselevatedincrt10Dmutants
Crt1 is an X-box DNA binding protein and represses the tran-
scription of RNR2,RNR3 and RNR4 through recruitment of the
corepressor complex Tup1-Ssn6; deletion of CRT1 elevated
the basal level expression of RNR3 25-fold (17). The above
epistatic analysis predicts that deletion of CRT10 may result in
an elevated RNR gene expression as well. The b-gal activities
of RNR3-lacZ and RNR2-lacZ transformants were measured in
the wild-type and isogenic crt10D mutants with or without
MMS or HU treatment. Indeed, the RNR3-lacZ and RNR2-
lacZ levels were elevated about 2-fold in crt10D mutants com-
pared to wild-type cells after treatment with DNA damaging
agents (Figure 3). This result is consistent with a real-time
PCR assay of the endogenous RNR3 transcript (Table 2),
suggesting that Crt10 functions as a transcriptional repressor
to regulate RNR2 and RNR3 in budding yeast.
In order to further demonstrate that CRT10 and CRT1
belong to the same regulatory pathway, we measured the
expression of RNR3-lacZ in wild-type, crt1D, crt10D single
and the crt1D crt10D double mutants by b-gal assay. As shown
in Table 3, the basal level of RNR3-lacZ was moderately
elevated in the crt10D mutant and dramatically elevated in
the crt1D mutant. Nevertheless, deletion of CRT10 does not
further enhance RNR3-lacZ expression in the crt1D mutant.
The same effect holds true after MMS treatment. These results
are consistent with the hypothesis that CRT10 and CRT1
function in the same pathway to regulate the transcription
of RNR genes.
CRT10 functions downstream of DUN1
The observation that crt1 is epistatic to crt10 with respect to
both HU resistance and RNR gene activity suggests that Crt1
most likely acts downstream of Crt10. The activity of Crt1 is
regulatedby itsphosphorylation state, and thephosphorylation
of Crt1 requires the protein kinase Dun1, although whether
Dun1 directly phosphorylates Crt1 remains to be determined
(17). In order to determine the genetic interaction between
CRT10 and DUN1,acrt10D dun1D double mutant was created
and compared to its corresponding single mutants with respect
to HU sensitivity. As seen in Figure 4A, whereas deletion of
DUN1 enhances HU sensitivity and deletion of CRT10 results
mec1∆ mec1∆ crt10∆ 
YPD YPD + 0.2 M HU
WT (BY4741)
crt1∆
crt10∆
YPD YPD + 0.3 M HU
WT (HK578)
sml1∆
crt10∆
A
B
C
crt1∆crt10∆
sml1∆crt10∆
Figure 2. Genetic interaction of CRT10 with CRT1 (A), SML1 (B) and
MEC1 (C). (A and B) Epistasis analysis. 10-fold serial dilutions of log-phase
cultures were spotted on YPD plates and on YPD plates containing HU as
described. Plates were incubated for 3 days at 30 C before photographing.
Strains used: (A) BY4741 (WT), WX1152 (crt10D), WX1153 (crt1D) and
WXY1154 (crt1D crt10D). (B) HK578-10A (WT), U952-3B (sml1D),
WXY1157 (crt10D) and WXY1159 (sml1D crt10D). (C) The inviability of
mec1D is partially rescued by deletion of CRT10. Tetrads resulting from a
cross of WXY1158 (MEC1 SML1 crt10D) and U953-61A (mec1D sml1D
CRT10) were dissected and the growth of each spore was followed by
microscopic analysis. The representative picture was taken after 4 day
incubation at 30 C.
Nucleic Acids Research, 2006, Vol. 34, No. 6 1879in HU resistance, cells carrying both deletions display
a phenotype indistinguishable from that of dun1D mutant.
Similarly, dun1 is epistatic to crt10 with respect to RNR3
expression, as deletion of CRT10 did not alter the
reduced RNR3 induction in the dun1 mutant (Figure 4B).
These observations indicate that the HU resistance and
increased RNR expression caused by CRT10 deletion require
functional Dun1.
Crt10 may act either upstream or downstream of Dun1.
Dun1 is a multi-functional protein involved in gene regulation
(21) as well as cell cycle checkpoints (34,35). Deletion of
DUN1 not only affects RNR gene induction, but also other
Table 2. Relative steady-state transcript level
Strain Relative transcript level
a
HK578-10D (WT) WXY1158 (crt10D)
Treatment  HU +0.2 M HU  HU +0.2 M HU
RNR3 1 9.14 2.71 26.74
MAG1 1 2.32 1.27 2.19
TUP1 1 1.20 0.94 1.09
SSN6 1 0.99 1.02 0.99
CRT1 1 2.06 0.38 0.50
aTranscriptlevelsweremeasuredbyreal-timePCRwithtotalmRNAfromcells
with or without treatment with 0.2 M HU for 1 h, and normalized to the
ACT1 transcript control. Untreated wild-type cells were used as a reference.
Experimental variations due to PCR is negligible.
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Figure 3. RNR gene expression in wild-type and crt10D cells. RNR3-lacZ (A and B) and RNR2-lacZ (C and D) expression was monitored after MMS (A,C) and
HU(B,D)treatments.b-galactivitywasdeterminedasdescribedinMaterialsandMethods.(filledsquare)BY4741(wildtype)and(filledcircle)WXY1152(crt10D)
were transformed with either pZZ2 (pRNR3-lacZ) or pZZ18 (pRNR2-lacZ) and several independent transformants were picked for analysis. The results are the
average of at least three independent experiments with standard deviations. b-gal activity is given in Miller units.
Table 3. b-gal activities of RNR3-lacZ in crt1D and crt10D mutants
Strain
a b-Galactosidaseactivity(Millerunits)
b
 MMS +0.02% MMS
BY4741 1.6 ± 0.12 48.9 ± 1.75
WXY1153 (crt1D) 72.5 ± 2.72 101.3 ± 3.51
WXY1152 (crt10D) 4.2 ± 0.32 85.5 ± 1.60
WXY1154 (crt1D crt10D) 73.8 ± 3.51 100.8 ± 2.74
aAll strains were transformed with pZZ2 (RNR3-lacZ).
bb-gal activity was measured as described in Materials and Methods. Data
represent the averages of at least three independent experiments with standard
deviations.
1880 Nucleic Acids Research, 2006, Vol. 34, No. 6DNA damage-inducible gene expression (36). We reasoned
that if Crt10 acts upstream of Dun1, its inactivation would
alter all Dun1-mediated activities. If, as previously observed,
Crt10 only affects a subset (i.e. RNR) of Dun1-mediated gene
expression; inactivation of Crt10 should not affect other gene
expression. For example, MAG1 induction by DNA damage
requires Dun1 (36); we found that its expression and induction
was not altered by deletion of CRT10 (Table 2), suggesting
that indeed Crt10 acts downstream of Dun1 and is speciﬁc for
RNR gene expression.
CRT10 is required for CRT1 expression and induction
The above genetic analyses ﬁt into a model that Crt10
functions as a positive regulator of Crt1 and/or its
co-repressors Tup1-Ssn6. We thus measured the transcript
levels of CRT1, TUP1 and SSN6 with or without HU treat-
ment. As shown in Table 2, deletion of CRT10 does not affect
the transcript level of TUP1 or SSN6 regardless of HU
treatment, but signiﬁcantly reduced the basal level as well
as HU-induced expression of CRT1. Hence, Crt10 appears
to serve as a positive regulator of Crt1 at the transcriptional
level.
Expression of CRT10 is elevated in response to
DNA damage and HU
Many genes involved in DNA metabolism (replication, repair
and recombination) are induced after treatment with DNA
damaging agents or replication blocking agents. In addition,
regulatory genes, such as CRT1 itself are up-regulated
in response to DNA damage or HU treatment in a DUN1-
dependent manner (17), indicative of an auto-regulatory cir-
cuit. We measured the CRT10 transcript level under treated
and untreated conditions and found that the CRT10 transcript
level is increased after treatment with MMS, HU and g-rays
(Figure 5A). Interestingly, there appear to be two transcripts
with slightly different sizes; the treatments induce expression
of both transcripts, but the higher molecular weight transcript
is induced more dramatically than the lower molecular weight
transcript. In order to address whether the transcriptional
regulation of CRT10 is dependent on other regulators in
this pathway, such as Crt1 and Dun1, we compared the
CRT10 transcript levels in the wild-type and mutant back-
grounds. The induction of CRT10 requires DUN1, as the
dun1 mutation completely abolished CRT10 induction,
whereas deletion of CRT1 has no effect on CRT10 expression
(Figure 5B).
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Figure 4. DUN1isepistatictoCRT10.(A)DeletionofDUN1abolishestheHU
resistancecausedbythecrt10mutation.10-foldserialdilutionswerespottedon
YPD plates and on YPD plates containing 0.1 M HU. Plates were incubated
for 3 days at 30 C before photographing. Strains used: BY4741 (WT),
WXY1152 (crt10D), WXY1155 (dun1D), WX1156 (crt10D dun1D). (B) The
CRT10 effect on RNR3 expression is dependent on DUN1. RNR3-lacZ expres-
sion was monitored with or without MMS treatment and expressed in Miller
units.Theresultsaretheaverageofatleastthreeindependentexperimentswith
standard deviations.
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Figure 5. (A) CRT10 expression in response to DNA damage and HU treat-
ment. Log-phase wild-type HK578-10A cells were either untreated (lane 1) or
treated with 0.3% MMS for 2 h (lane 2), 0.2 M HU for 2 h (lane 3) or exposed
to 40 krad of g radiation (lane 4). (B) CRT10 induction is DUN1-dependent.
Log-phase wild-type BY4741 and its derivatives WXY1153 (crt1D) and
WXY1155 (dun1D) were either untreated ( ) or treated with 0.1% MMS
for 2 h (+). Northern hybridization was performed as described in Materials
and Methods. The membranes were hybridized with CRT10 (upper panel),
stripped and then hybridized with ACT1 (lower panel) as an internal control.
Each lane contains 15 mg of total RNA.
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We report here the isolation and initial characterization of
CRT10 as a novel yeast gene involved in the transcriptional
regulation of RNR genes. Rnr catalyzes a rate-limiting step in
the production of dNTPs, whose levels are critical to many
cellular functions (10). Imbalanced or insufﬁcient dNTP pools
lead to enhanced misincorporation, high mutation frequencies
and impaired DNA repair (11). Due to its vital importance to
cellular physiology, it is not surprising that Rnr is tightly
regulated via multiple mechanisms and at different stages.
Our results suggest that Crt10 is a newly discovered negative
regulator of RNR genes and acts at the transcriptional level.
First, deletion of CRT10 results in enhanced cellular resistance
to HU, an Rnr inhibitor. Second, deletion of CRT10 enhances
the survival of the mec1 null mutant, reminiscent of other
suppressors of mec1 and rad53 inviability, all of which lead
to increased Rnr activities (17,18,20,33). Third, deletion of
CRT10 in wild-type cells results in an increased expression of
RNR genes coding for both large and small Rnr subunits, in the
presence and absence of DNA damage, which provides under-
lying mechanisms of HU resistance. Results obtained from
epistasis analyses suggest that Crt10 functions downstream
of Dun1 and probably upstream of or together with Crt1
(Figure 6). Nevertheless, both dun1 and crt1 are epistatic to
crt10, suggesting that Crt10 is probably a regulatory compon-
ent in the Dun1-Crt1 signal transduction pathway leading to
the control of RNR gene expression. Finally, our observation
that deletionof CRT10 reduces CRT1 expression and abolishes
the DNA damage induction of CRT1 provides direct evidence
that CRT10 functions through positive regulation of CRT1
expression.
The physiological signiﬁcance of RNR suppression by
CRT10 is presently unclear; however, one interesting
observation through this study is that CRT10 itself is induced
after DNA damage and HU treatment, suggesting that Crt10
playsacritical roleinrespondingtoreplicationblocks.Several
pieces of evidence indicate that Crt10 achieves this objective
through delicate regulation of the endogenous dNTP pool, as
illustrated in Figure 6. Firstly, Crt10 acts as a negative regu-
lator to counterbalance the dNTP pool. In the presence of
replication blocks (DNA damage) or with an exhausted
dNTP pool (HU treatment to inhibit Rnr activity), all four
RNR genes are upregulated and Sml1 activity is inhibited,
leading to enhanced dNTP production. The increased Crt10
activity may be required to bring Rnr activity back to a normal
levelonceorderisrestored. Inthisrespect,it isofgreatinterest
to notice that the optimal dose required to induce CRT10 is
higher than that required to induce RNR genes (37), which is
consistent with the notion that CRT10 induction may lag
behind that of RNR genes. Secondly, like CRT1 (17), the
induction of CRT10 itself depends on DUN1, suggesting
that Crt10 functions downstream of Dun1 and forms another
component of the autoregulatory circuit. However, the effect
of CRT10 deletion on RNR gene expression is much less than
that of CRT1 deletion and, unlike CRT1, the CRT10 promoter
does not contain the X-box sequence recognized by Crt1 (17).
This is not unprecedented since DNA damage induction of
several other genes also requires DUN1 in the absence of the
X-box sequence (36). Finally, in addition to its roles in
modulating and maintaining an optimal dNTP pool under
stress conditions, CRT10 appears to be required for optimal
growth in the absence of exogenous DNA damage/replication
blocks, since a recent genetic footprinting study (38) showed
that deletion of CRT10 causes an apparently severe growth
defect in rich medium after 20 generations, in minimal
medium as well as medium containing NaCl. These observa-
tions imply that vigorous modulation of the endogenous
dNTP pool by CRT10 is critical to achieve optimal cell
growth, possibly by maintaining proper DNA synthesis and
cell division. Alternatively, CRT10 may play roles in optim-
izing cell growth by a mechanism other than affecting Rnr
activity.
Despite the strong genetic evidence that Crt10 is involved
in the transcriptional regulation of RNR genes and CRT1, its
biochemical activity remains obscure. The leucine repeats and
a single WD motif suggest that Crt10 may interact with
other protein(s), although to date no such proteins have
been identiﬁed through systematic studies. It does not contain
a domain/motif indicative of its catalytic function; however,
the protein is apparently conserved and widespread within
unicellular lower eukaryotes. Future investigations will
attempt to uncover biological and biochemical functions
of Crt10.
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